Tube formation assays confirmed that Stattic blocked the proangiogenic effect of OCLN overexpression (Figure 4B,C), indicating that STAT3 was involved in OCLN‐modified modulation of tumour angiogenesis in BLCA. The gene discussed is STAT3; the disease is bladder transitional cell carcinoma.